Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

23 ta ish

Ish: Lipoproteinuria as an independent predictor of unfavorable outcome after intravenous thrombolysis in ischaemic stroke

  1. Prevalence of Chronic Kidney Disease in the United States

    Josef Coresh, Elizabeth Selvin, Lesley A. Stevens +5

    Maqola20074 iqtibos
    ABI

  2. Sarlavhasiz

    Boshqa3 iqtibos
    ABI

  3. Canadian Guidelines for Intravenous Thrombolytic Treatment in Acute Stroke: A Consensus Statement of The Canadian Stroke Consortium

    J W Norris, Alastair M. Buchan, Robert Côté +6

    Maqola19983 iqtibos
    ABI

  4. Reduced Estimated Glomerular Filtration Rate Is Associated with Stroke Outcome after Intravenous rt-PA: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry

    Masaki Naganuma, Masatoshi Koga, Yoshiaki Shiokawa +11

    Maqola20103 iqtibos
    ABI

  5. Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage

    Peter Ochodnický, Robert H. Henning, Richard P.E. van Dokkum +1

    Sharh maqola20063 iqtibos
    ABI

  6. Proteinuria and Stroke: A Meta-analysis of Cohort Studies

    Toshiharu Ninomiya, Vlado Perkovic, Christine Verdon +8

    Sharh maqola20083 iqtibos
    ABI

  7. Microalbuminuria: Risk factor and potential therapeutic target for stroke?

    Bruce Ovbiagele

    Sharh maqola20083 iqtibos
    ABI

  8. Prediction of hemorrhagic transformation in acute ischaemic stroke by micro‐ and macroalbuminuria after intravenous thrombolysis

    Bang-Hoon Cho, Joon‐Tae Kim, Jason J. Chang +3

    Maqola20133 iqtibos
    ABI

  9. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan

    Chi Pang Wen, Ting Cheng, Min Kuang Tsai +8

    Maqola20083 iqtibos
    ABI

  10. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC‐Norfolk) population study

    Matthew F. Yuyun, K.‐T. Khaw, Robert Luben +4

    Maqola20043 iqtibos
    ABI

  11. Renal function and outcome among stroke patients treated with IV thrombolysis

    Philippe Lyrer, Felix Fluri, D. Gisler +3

    Maqola20083 iqtibos
    ABI

  12. Feasibility and Safety of Intravenous Thrombolysis in Multiethnic Asian Stroke Patients in Singapore

    Vijay K. Sharma, Georgios Tsivgoulis, June H. Tan +4

    Maqola20103 iqtibos
    ABI

  13. The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

    Keith A.A. Fox, Elliott M. Antman, Gilles Montalescot +7

    Maqola20073 iqtibos
    ABI

  14. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study

    Nils Wahlgren, Niaz Ahmed, Antoni Dávalos +12

    Maqola20073 iqtibos
    ABI

  15. The Effects of Eprosartan Mesylate and Lercanidipine on Reducing Microalbuminuria in Patients with Nephropathy due to Type 2 Diabetes

    Botir T. Daminov, PhD, ScD, Sherzod Abdullaev

    Maqola20133 iqtibos
    ABI

  16. Tissue-plasminogen activator for acute ischaemic stroke

    Askiel Bruno

    Boshqa19972 iqtibos
    ABI

  17. Thrombogenic factors are related to urinary albumin excretion rate in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients

    Paul Knöbl, G. Schernthaner, Ch. Schnack +4

    Maqola19932 iqtibos
    ABI

  18. Chronic Kidney Disease and Clinical Outcome in Patients With Acute Stroke

    Gilad Yahalom, Roseline Schwartz, Yvonne Schwammenthal +5

    Maqola20092 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI